Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C14H23N3O3S |
| Molecular Weight | 313.416 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCN(CC)CCNC(=O)C1=CC=C(NS(C)(=O)=O)C=C1
InChI
InChIKey=KHYPYQZQJSBPIX-UHFFFAOYSA-N
InChI=1S/C14H23N3O3S/c1-4-17(5-2)11-10-15-14(18)12-6-8-13(9-7-12)16-21(3,19)20/h6-9,16H,4-5,10-11H2,1-3H3,(H,15,18)
Originator
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Lesion evidence that two distinct regions within prefrontal cortex are critical for n-back performance in humans. | 2009-12 |
|
| Relationship among amiodarone, new class III antiarrhythmics, miscellaneous agents and acquired long QT syndrome. | 2008 |
|
| Effects of a novel cyclohexane dicarboximide derivative, ST-6, on reperfusion-induced arrhythmia in rats. | 2005-05 |
|
| [Effects of clinically available drugs on the repolarization process of the heart assessed by the in vivo canine models]. | 2003-06 |
|
| Comparison of the in vivo electrophysiological and proarrhythmic effects of amiodarone with those of a selective class III drug, sematilide, using a canine chronic atrioventricular block model. | 2002-08 |
|
| Effects of a typical I(Kr) channel blocker sematilide on the relationship between ventricular repolarization, refractoriness and onset of torsades de pointes. | 2002-04 |
|
| Pharmacology of the class III antiarrhythmic agent sematilide in patients with arrhythmias. | 1992-01-15 |
|
| Synthesis and cardiac electrophysiological activity of aryl-substituted derivatives of the class III antiarrhythmic agent sematilide. Potential class I/III agents. | 1990-02 |
Patents
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C47793
Created by
admin on Mon Mar 31 19:16:49 GMT 2025 , Edited by admin on Mon Mar 31 19:16:49 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
SEMATILIDE
Created by
admin on Mon Mar 31 19:16:49 GMT 2025 , Edited by admin on Mon Mar 31 19:16:49 GMT 2025
|
PRIMARY | |||
|
C062818
Created by
admin on Mon Mar 31 19:16:49 GMT 2025 , Edited by admin on Mon Mar 31 19:16:49 GMT 2025
|
PRIMARY | |||
|
C152329
Created by
admin on Mon Mar 31 19:16:49 GMT 2025 , Edited by admin on Mon Mar 31 19:16:49 GMT 2025
|
PRIMARY | |||
|
m9851
Created by
admin on Mon Mar 31 19:16:49 GMT 2025 , Edited by admin on Mon Mar 31 19:16:49 GMT 2025
|
PRIMARY | Merck Index | ||
|
0NHB13IN3R
Created by
admin on Mon Mar 31 19:16:49 GMT 2025 , Edited by admin on Mon Mar 31 19:16:49 GMT 2025
|
PRIMARY | |||
|
58505
Created by
admin on Mon Mar 31 19:16:49 GMT 2025 , Edited by admin on Mon Mar 31 19:16:49 GMT 2025
|
PRIMARY | |||
|
DTXSID0058720
Created by
admin on Mon Mar 31 19:16:49 GMT 2025 , Edited by admin on Mon Mar 31 19:16:49 GMT 2025
|
PRIMARY | |||
|
CHEMBL95804
Created by
admin on Mon Mar 31 19:16:49 GMT 2025 , Edited by admin on Mon Mar 31 19:16:49 GMT 2025
|
PRIMARY | |||
|
6157
Created by
admin on Mon Mar 31 19:16:49 GMT 2025 , Edited by admin on Mon Mar 31 19:16:49 GMT 2025
|
PRIMARY | |||
|
SUB10478MIG
Created by
admin on Mon Mar 31 19:16:49 GMT 2025 , Edited by admin on Mon Mar 31 19:16:49 GMT 2025
|
PRIMARY | |||
|
101526-83-4
Created by
admin on Mon Mar 31 19:16:49 GMT 2025 , Edited by admin on Mon Mar 31 19:16:49 GMT 2025
|
PRIMARY | |||
|
100000084109
Created by
admin on Mon Mar 31 19:16:49 GMT 2025 , Edited by admin on Mon Mar 31 19:16:49 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)